United States CD163(Antibody) Market was valued at USD 0.2 Billion in 2022 and is projected to reach USD 0.5 Billion by 2030, growing at a CAGR of 12% from 2024 to 2030.
The US CD163 (Antibody) market is experiencing a surge in demand across various industries due to its critical role in immune modulation and disease diagnosis. This specialized antibody targets the CD163 protein, primarily found on macrophages, which makes it essential in understanding numerous inflammatory and autoimmune diseases. With the growing prevalence of chronic diseases, the requirement for CD163 in both research and clinical diagnostics has become increasingly vital.
The healthcare and pharmaceutical industries are the primary consumers of CD163 antibodies. Researchers are using these antibodies to explore new therapeutic targets for conditions such as cancer, autoimmune disorders, and infections. Clinical diagnostic labs also rely on CD163 antibodies to detect and monitor diseases such as sepsis and cardiovascular conditions. The increased need for precision medicine and personalized therapies has further fueled the demand for such specialized antibodies.
One of the most notable trends in the US CD163 (Antibody) market is the rise of biopharmaceutical companies incorporating these antibodies in their drug development pipeline. In these industries, CD163 antibodies are indispensable tools for studying disease mechanisms and validating new drug candidates. Furthermore, the growing number of clinical trials focused on immune modulation therapies has increased the production of CD163 antibodies, which are being used in preclinical and clinical research.
In addition to medical research and diagnostics, the biotechnology sector is also driving demand for CD163 antibodies. These antibodies are increasingly being integrated into cellular therapies and immunotherapies aimed at improving treatment outcomes for chronic illnesses. As companies continue to develop innovative treatments, CD163 antibodies remain a key component in advancing therapeutic options.
The demand for high-quality, validated antibodies such as CD163 is expected to continue its upward trajectory, driven by increasing research efforts, medical advancements, and the ongoing need for better diagnostic tools. As industries continue to prioritize precision medicine, CD163 antibodies will play a pivotal role in meeting these requirements, shaping the future of medical treatments and diagnostics.
100 Gigabit Fiber Optic Transceiver Market Type and requirement from industries are also growing alongside innovations in medical technologies like CD163 antibodies. Both industries rely on advanced technologies to drive efficiency and precision, highlighting the interconnectedness of technological advancements in healthcare and telecommunications sectors.
Get an In-Depth Research Analysis of the US CD163(Antibody) Market Size And Forecast [2025-2032]
Key Player I
Key Player II
Key Player III
Key Player IV
Key Player V
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US CD163(Antibody) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US CD163(Antibody) Market
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Antibody Fragments (e.g., Fab, scFv)
Diagnostic Applications
Therapeutics
Research and Development
Companion Diagnostics
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Diagnostics Laboratories
Immunohistochemistry (IHC)
Flow Cytometry
Enzyme-Linked Immunosorbent Assay (ELISA)
Western Blotting
Human-Derived
Animal-Derived
Recombinant Sources
Hybridoma Technology
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ CD163(Antibody) Market Research Analysis
1. Introduction of the US CD163(Antibody) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US CD163(Antibody) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US CD163(Antibody) Market, By Type
6. US CD163(Antibody) Market, By Application
7. US CD163(Antibody) Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US CD163(Antibody) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/